CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Microangiopathic haemolytic anaemia as a bad prognostic paraneoplastic syndrome: a case report

Author: 
Bárbara Pereira Machado and Gonçalo Sarmento
Subject Area: 
Health Sciences
Abstract: 

Introduction: Microangiopathic haemolytic anaemia is defined by evidence of haemolysis, schistocytes in the peripheral blood smear and a negative direct antiglobulin test and is usually associated with thrombocytopenia. It may be primary, like thrombotic thrombocytopenic purpura, or secondary, including systemic malignancy, which is very rare. It usually occurs at a terminal stage of cancer and it is associated with metastasis. Pathogenesis remains unknown. Case presentation: An 83 year- old- woman with diffuse metastatic right breast carcinoma, including bone marrow metastases suspicion, already submitted to mastectomy and palliative radiotherapy, presented with a two-week history of asthenia and dyspnoea. Routine analysis revealed acute normocytic normochromic, haemolytic anaemia, schistocytes in the peripheral blood smear, negative Coombs test and thrombocytopenia. Space-occupying lesions of the brain observed in CT scan were confirmed by RM to be brain metastasis. Because the initial diagnosis of cancer was already known, no further investigation was made, and cancer associated microangiopathic haemolytic anaemia was diagnosed. She was no candidate to antineoplastic treatment, so she received prednisolone for 4 days followed by a pulse regimen of 1g methylprednisolone daily for 3 consecutive days. Several transfusions were given, but there was little improvement of anaemia. The patient’s health condition continued to worsen resulting in her passing. Conclusion: It is very important to correctly diagnose cancer associated microangiopathic haemolytic anaemia in order to start the right treatment as soon as possible. Even today there exists no definitive treatment schedule for these patients. Systemic antineoplastic therapy is the best option to achieve clinical response. Despite this, the prognosis is extremely poor, most patients die within a few weeks after diagnosis

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran